FUSION ANTIBODIES PLC ORD 4P吧
排序：
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
32 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 06-02 14:20
25 0 公告 Update on U.S. Patent for OptiMAL？ FUSION ANTIBODIE资讯 05-22 21:36
36 0 公告 Investor presentation FUSION ANTIBODIE资讯 05-08 14:59
28 0 公告 Issue of shares to non-executive directors FUSION ANTIBODIE资讯 05-07 14:17
30 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 05-06 17:56
34 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 05-06 17:43
24 0 公告 Trading update FUSION ANTIBODIE资讯 05-06 14:44
37 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 05-01 00:03
30 0 公告 Approval of grant funding FUSION ANTIBODIE资讯 04-24 14:15
27 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 04-11 17:45
28 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 04-10 19:50
27 0 公告 Result of General Meeting FUSION ANTIBODIE资讯 04-07 19:42
41 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 04-01 00:02
30 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 03-25 00:41
30 0 公告 Placing to raise approximately ￡1.17 million FUSION ANTIBODIE资讯 03-18 15:18
28 0 公告 Contract win FUSION ANTIBODIE资讯 02-27 15:18
52 0 公告 OptiMAL R&D Update FUSION ANTIBODIE资讯 01-31 15:12
62 0 公告 Approval of Grant Funding Application FUSION ANTIBODIE资讯 12-04 19:34
66 0 公告 Half-year Report FUSION ANTIBODIE资讯 11-19 15:15
62 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 10-16 20:28
63 0 公告 Issue of shares to non-executive directors FUSION ANTIBODIE资讯 10-16 14:12
55 0 公告 Result of AGM FUSION ANTIBODIE资讯 10-08 19:35
69 0 公告 AGM statement and trading update FUSION ANTIBODIE资讯 10-08 14:20
63 0 公告 Block admission six monthly return FUSION ANTIBODIE资讯 10-02 14:12
65 0 公告 Notice of AGM FUSION ANTIBODIE资讯 09-12 16:57
77 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 09-09 19:38
73 0 公告 Investor presentation FUSION ANTIBODIE资讯 09-09 14:19
72 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 09-05 19:18
67 0 公告 Final Results FUSION ANTIBODIE资讯 09-05 14:12
74 0 公告 Expansion to OptiMAL collaboration agreement FUSION ANTIBODIE资讯 08-28 15:12
70 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 07-22 21:02
64 0 公告 Launch of New Interactive Investor Hub FUSION ANTIBODIE资讯 07-18 15:08
93 0 公告 Trading update FUSION ANTIBODIE资讯 07-04 15:08
57 0 公告 New contract with existing client FUSION ANTIBODIE资讯 05-23 15:08
65 0 公告 Investor presentation FUSION ANTIBODIE资讯 05-02 15:23
75 0 公告 Year-end trading statement FUSION ANTIBODIE资讯 04-30 15:13
72 0 公告 Change of auditor FUSION ANTIBODIE资讯 04-16 15:07
68 0 公告 Contract to develop a bespoke OptiPhage library FUSION ANTIBODIE资讯 04-15 15:12
64 0 公告 Block admission six monthly return FUSION ANTIBODIE资讯 04-02 22:45
68 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 03-29 02:06
72 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 03-12 00:17
57 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 03-11 18:18
67 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 03-09 00:17
89 0 公告 Result of General Meeting and Total Voting Rights FUSION ANTIBODIE资讯 03-05 19:47
85 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 03-01 02:07
79 0 公告 First purchase order under MSA FUSION ANTIBODIE资讯 02-27 16:08
89 0 公告 Grant of options and issue of shares to directors FUSION ANTIBODIE资讯 02-14 16:23
77 0 公告 Placing to raise ￡1,375,000 FUSION ANTIBODIE资讯 02-14 16:08
81 0 公告 Follow-on project award and R&D update FUSION ANTIBODIE资讯 02-06 16:07
82 0 公告 HMRC R&D tax credit FUSION ANTIBODIE资讯 02-01 16:44
82 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 12-04 21:32
94 0 公告 Half-year Report FUSION ANTIBODIE资讯 12-04 16:10
89 0 公告 OptiMAL collaboration agreement FUSION ANTIBODIE资讯 11-28 16:10
73 0 公告 Half year trading update FUSION ANTIBODIE资讯 11-09 16:38
91 0 公告 Result of AGM FUSION ANTIBODIE资讯 10-27 20:03
103 0 公告 Block admission six monthly return FUSION ANTIBODIE资讯 10-04 22:53
109 0 公告 Final Results FUSION ANTIBODIE资讯 09-29 15:09
80 0 公告 Update on AI/ML-Ab service offering FUSION ANTIBODIE资讯 08-29 15:08
76 0 公告 Appointment of interim CFO FUSION ANTIBODIE资讯 08-24 15:08
91 0 公告 Update on AI/ML-Ab antibody discovery service FUSION ANTIBODIE资讯 08-21 15:09
92 0 公告 Update on restructure and cost savings FUSION ANTIBODIE资讯 08-14 15:08
90 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 07-01 01:12
78 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 06-16 18:38
83 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 06-15 17:53
79 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 06-13 22:50
95 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 06-12 23:42
74 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 06-12 19:13
84 0 公告 Result of GM and total voting rights FUSION ANTIBODIE资讯 06-08 18:46
107 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 06-01 01:11
189 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 05-27 01:07
125 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 05-26 21:49
113 0 公告 Result of Retail Offer and Notice of GM FUSION ANTIBODIE资讯 05-23 15:09
121 0 公告 REX Retail Offer FUSION ANTIBODIE资讯 05-19 18:10
126 0 公告 Placing, Subscription and Retail Offer FUSION ANTIBODIE资讯 05-19 18:08
140 0 公告 Block listing Interim Review FUSION ANTIBODIE资讯 04-03 15:03
134 0 公告 Change of Registered Office FUSION ANTIBODIE资讯 03-31 15:03
152 0 公告 Patent application FUSION ANTIBODIE资讯 03-21 15:05
118 0 公告 Second Price Monitoring Extn FUSION ANTIBODIE资讯 03-06 20:21
137 0 公告 Price Monitoring Extension FUSION ANTIBODIE资讯 03-06 20:06
187 0 公告 Trading Statement FUSION ANTIBODIE资讯 03-06 16:09
发表新主题
悬赏提问
帖子不见了！怎么办？   
   请登录 登录 | 5秒注册 作者： 退出 
郑重声明：用户在社区发表的所有资料、言论等仅代表个人观点，与本网站立场无关，不对您构成任何投资建议。用户应基于自己的独立判断，自行决定证券投资并承担相应风险。《东方财富社区管理规定》
东方财富

扫一扫下载APP
东方财富产品
证券交易
关注东方财富
天天基金

扫一扫下载APP
基金交易
关注天天基金
东方财富期货

扫一扫下载APP
期货交易
信息网络传播视听节目许可证：0908328号 经营证券期货业务许可证编号：913101046312860336 违法和不良信息举报:021-34289898 举报邮箱：jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500
关于我们 广告服务 联系我们 诚聘英才 免责声明 法律声明 隐私保护 征稿启事 放心搜 友情链接